Skip to main content
Top
Published in: Journal of Nuclear Cardiology 5/2013

01-10-2013 | Original Article

12-Year outcome after normal myocardial perfusion SPECT in patients with known coronary artery disease

Authors: Machiel J. M. Ottenhof, BSc, Marisa C. G. Tjong Joe Wai, BSc, Hendrik J. Boiten, BSc, Rebecca S. Korbee, BSc, Roelf Valkema, MD, PhD, Ron T. van Domburg, PhD, Arend F. L. Schinkel, MD, PhD

Published in: Journal of Nuclear Cardiology | Issue 5/2013

Login to get access

Abstract

Background

Previous studies have reported a favorable outcome of patients with normal single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI). The aim of this study was to assess the very long-term prognosis of patients with known coronary artery disease (CAD) and normal SPECT MPI results.

Methods

The population consisted of 266 patients with known CAD (defined as a healed myocardial infarction and/or a previous coronary revascularization), who underwent exercise bicycle or dobutamine-atropine stress SPECT MPI and had normal perfusion during stress and at rest. End points during follow-up were all-cause mortality, cardiac mortality, and nonfatal myocardial infarction. Univariate and multivariate analyses were performed to identify predictors of long-term outcome.

Results

Follow-up was completed in 261 (98%) patients. During a median follow-up of 12 years, 94 (36%) patients died, of which 26 (10%) died due to cardiac causes, and 15 (6%) had a nonfatal myocardial infarction. The annualized mortality rate was 3.1%, annualized cardiac mortality rate was 0.9%, and the annualized event rate for cardiac death and/or nonfatal infarction was 1.2%. Independent predictors of total mortality were age, diabetes mellitus, and rate-pressure product at peak stress. Independent predictors of cardiac mortality were age, male gender, and rate-pressure product at peak stress.

Conclusion

Patients with known CAD and a normal SPECT MPI study have a favorable long-term prognosis. Clinical and stress test variables can be used to identify patients with a higher risk status.
Literature
1.
go back to reference Beller GA, Zaret BL. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation 2000;101:1465-78.PubMedCrossRef Beller GA, Zaret BL. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation 2000;101:1465-78.PubMedCrossRef
2.
go back to reference Schinkel AF, Bax JJ, Geleijnse ML, Boersma E, Elhendy A, Roelandt JR, et al. Noninvasive evaluation of ischaemic heart disease: Myocardial perfusion imaging or stress echocardiography? Eur Heart J 2003;24:789-800.PubMedCrossRef Schinkel AF, Bax JJ, Geleijnse ML, Boersma E, Elhendy A, Roelandt JR, et al. Noninvasive evaluation of ischaemic heart disease: Myocardial perfusion imaging or stress echocardiography? Eur Heart J 2003;24:789-800.PubMedCrossRef
3.
go back to reference Shaw LJ, Hendel R, Borges-Neto S, Lauer MS, Alazraki N, Burnette J, et al. Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: Results from the multicenter registry of 4,728 patients. J Nucl Med 2003;44:134-9.PubMed Shaw LJ, Hendel R, Borges-Neto S, Lauer MS, Alazraki N, Burnette J, et al. Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: Results from the multicenter registry of 4,728 patients. J Nucl Med 2003;44:134-9.PubMed
4.
go back to reference Metz LD, Beattie M, Hom R, Redberg RF, Grady D, Fleischmann KE. The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: A meta-analysis. J Am Coll Cardiol 2007;49:227-37.PubMedCrossRef Metz LD, Beattie M, Hom R, Redberg RF, Grady D, Fleischmann KE. The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: A meta-analysis. J Am Coll Cardiol 2007;49:227-37.PubMedCrossRef
5.
go back to reference Schinkel AF, Elhendy A, Bax JJ, van Domburg RT, Huurman A, Valkema R, et al. Prognostic implications of a normal stress technetium-99m-tetrofosmin myocardial perfusion study in patients with a healed myocardial infarct and/or previous coronary revascularization. Am J Cardiol 2006;97:1-6.PubMedCrossRef Schinkel AF, Elhendy A, Bax JJ, van Domburg RT, Huurman A, Valkema R, et al. Prognostic implications of a normal stress technetium-99m-tetrofosmin myocardial perfusion study in patients with a healed myocardial infarct and/or previous coronary revascularization. Am J Cardiol 2006;97:1-6.PubMedCrossRef
6.
go back to reference Schinkel AF, Elhendy A, van Domburg RT, Bax JJ, Vourvouri EC, Bountioukos M, et al. Incremental value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography for the prediction of cardiac events. Am J Cardiol 2003;91:408-11.PubMedCrossRef Schinkel AF, Elhendy A, van Domburg RT, Bax JJ, Vourvouri EC, Bountioukos M, et al. Incremental value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography for the prediction of cardiac events. Am J Cardiol 2003;91:408-11.PubMedCrossRef
7.
go back to reference Schinkel AF, Elhendy A, van Domburg RT, Bax JJ, Roelandt JR, Poldermans D. Prognostic value of dobutamine-atropine stress (99m)Tc-tetrofosmin myocardial perfusion SPECT in patients with known or suspected coronary artery disease. J Nucl Med 2002;43:767-72.PubMed Schinkel AF, Elhendy A, van Domburg RT, Bax JJ, Roelandt JR, Poldermans D. Prognostic value of dobutamine-atropine stress (99m)Tc-tetrofosmin myocardial perfusion SPECT in patients with known or suspected coronary artery disease. J Nucl Med 2002;43:767-72.PubMed
8.
go back to reference Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69.PubMedCrossRef Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69.PubMedCrossRef
9.
go back to reference Cox DR. Regression models and life-tables. J R Stat Soc (B) 1972;34:187-202. Cox DR. Regression models and life-tables. J R Stat Soc (B) 1972;34:187-202.
10.
go back to reference Georgoulias P, Demakopoulos N, Tzavara C, Giannakou S, Valotassiou V, Tsougos I, et al. Long-term prognostic value of Tc-99m tetrofosmin myocardial gated-SPECT imaging in asymptomatic patients after percutaneous coronary intervention. Clin Nucl Med 2008;33:743-7.PubMedCrossRef Georgoulias P, Demakopoulos N, Tzavara C, Giannakou S, Valotassiou V, Tsougos I, et al. Long-term prognostic value of Tc-99m tetrofosmin myocardial gated-SPECT imaging in asymptomatic patients after percutaneous coronary intervention. Clin Nucl Med 2008;33:743-7.PubMedCrossRef
11.
go back to reference Acampa W, Petretta M, Evangelista L, Nappi G, Luongo L, Petretta MP, et al. Stress cardiac single-photon emission computed tomographic imaging late after coronary artery bypass surgery for risk stratification and estimation of time to cardiac events. J Thorac Cardiovasc Surg 2008;136:46-51.PubMedCrossRef Acampa W, Petretta M, Evangelista L, Nappi G, Luongo L, Petretta MP, et al. Stress cardiac single-photon emission computed tomographic imaging late after coronary artery bypass surgery for risk stratification and estimation of time to cardiac events. J Thorac Cardiovasc Surg 2008;136:46-51.PubMedCrossRef
12.
go back to reference Hachamovitch R, Hayes S, Friedman JD, Cohen I, Shaw LJ, Germano G, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans. What is the warranty period of a normal scan? J Am Coll Cardiol 2003;41:1329-40.PubMedCrossRef Hachamovitch R, Hayes S, Friedman JD, Cohen I, Shaw LJ, Germano G, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans. What is the warranty period of a normal scan? J Am Coll Cardiol 2003;41:1329-40.PubMedCrossRef
Metadata
Title
12-Year outcome after normal myocardial perfusion SPECT in patients with known coronary artery disease
Authors
Machiel J. M. Ottenhof, BSc
Marisa C. G. Tjong Joe Wai, BSc
Hendrik J. Boiten, BSc
Rebecca S. Korbee, BSc
Roelf Valkema, MD, PhD
Ron T. van Domburg, PhD
Arend F. L. Schinkel, MD, PhD
Publication date
01-10-2013
Publisher
Springer US
Published in
Journal of Nuclear Cardiology / Issue 5/2013
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-013-9713-3

Other articles of this Issue 5/2013

Journal of Nuclear Cardiology 5/2013 Go to the issue